Evidence map›Paper›PMID 32203463›Full record

ArticleNature genetics2020

Gene network transitions in embryos depend upon interactions between a pioneer transcription factor and core histones.

Makiko Iwafuchi, Isabel Cuesta, Greg Donahue, Naomi Takenaka, Anna B Osipovich, Mark A Magnuson, Heinrich Roder, Steven H Seeholzer, Pilar Santisteban, Kenneth S Zaret

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Circadian regulator REV-ERBα is a master regulator of tumor lineage plasticity and an effective therapeutic target.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. HIRA and dPCIF1 coordinately establish totipotent chromatin and control orderly ZGA inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Makiko IwafuchiInstitute for Regenerative Medicine, Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. makiko.iwafuchi@cchmc.org.ORCID http://orcid.org/0000-0003-1291-6246
Isabel CuestaInstituto de Investigaciones Biomédicas 'Alberto Sols', Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Madrid, Spain.
Greg DonahueInstitute for Regenerative Medicine, Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Naomi TakenakaInstitute for Regenerative Medicine, Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Anna B OsipovichDepartment of Molecular Physiology and Biophysics and Center for Stem Cell Biology, Vanderbilt University, Nashville, TN, USA.
Mark A MagnusonDepartment of Molecular Physiology and Biophysics and Center for Stem Cell Biology, Vanderbilt University, Nashville, TN, USA.
Heinrich RoderMolecular Therapeutics, Fox Chase Cancer Center, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-1860-2491
Steven H SeeholzerChildren's Hospital of Philadelphia, Philadelphia, PA, USA.
Pilar SantistebanInstituto de Investigaciones Biomédicas 'Alberto Sols', Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Madrid, Spain.
Kenneth S ZaretInstitute for Regenerative Medicine, Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. zaret@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0001-8932-3145
California Institute for Regenerative Medicine · USConsejo Superior de Investigaciones Científicas · ESVanderbilt University · USChildren's Hospital of Philadelphia · USCincinnati Children's Hospital Medical Center · USFox Chase Cancer Center · US

Funding

TRANS-ACTING FACTORS CAUSING CELL-SPECIFIC GENE CONTROLR01GM036477 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI ZARET, KENNETH · 1986 to 2023
$7.7M
Trans-acting Factors Causing Cell Specific Gene ControlR37GM036477 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI ZARET, KENNETH · 2006 to 2015
$5.4M
NIGMS NIH HHS R01 GM036477NIGMS NIH HHS R37 GM036477
6 · The paper itself

Abstract

Gene network transitions in embryos and other fate-changing contexts involve combinations of transcription factors. A subset of fate-changing transcription factors act as pioneers; they scan and target nucleosomal DNA and initiate cooperative events that can open the local chromatin. However, a gap has remained in understanding how molecular interactions with the nucleosome contribute to the chromatin-opening phenomenon. Here we identified a short α-helical region, conserved among FOXA pioneer factors, that interacts with core histones and contributes to chromatin opening in vitro. The same domain is involved in chromatin opening in early mouse embryos for normal development. Thus, local opening of chromatin by interactions between pioneer factors and core histones promotes genetic programming.

Indexed as

Amino Acid SequenceAnimalsCell LineChromatinDNAFemaleGene Expression Regulation, DevelopmentalGene Regulatory NetworksHistonesHumansMiceMice, Inbred C57BLNucleosomesTranscription FactorsTranscription, GeneticChromatinDNAHistonesNucleosomesTranscription Factors

Identifiers

PMID32203463
PMCPMC7901023
OpenAlexW3011108872

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.